- Home
- RENB vs CFSB Comparison
RENB vs CFSB Comparison
Compare RENB & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENB
- CFSB
- Stock Information
- Founded
- RENB 2011
- CFSB 1889
- Country
- RENB United States
- CFSB United States
- Employees
- RENB N/A
- CFSB N/A
- Industry
- RENB Biotechnology: Pharmaceutical Preparations
- CFSB Major Banks
- Sector
- RENB Health Care
- CFSB Finance
- Exchange
- RENB Nasdaq
- CFSB Nasdaq
- Market Cap
- RENB 57.7M
- CFSB 51.6M
- IPO Year
- RENB N/A
- CFSB N/A
- Fundamental
- Price
- RENB $0.26
- CFSB $13.94
- Analyst Decision
- RENB
- CFSB
- Analyst Count
- RENB 0
- CFSB 0
- Target Price
- RENB N/A
- CFSB N/A
- AVG Volume (30 Days)
- RENB 866.4K
- CFSB 1.4K
- Earning Date
- RENB 10-09-2025
- CFSB 09-09-2025
- Dividend Yield
- RENB N/A
- CFSB N/A
- EPS Growth
- RENB N/A
- CFSB N/A
- EPS
- RENB N/A
- CFSB N/A
- Revenue
- RENB N/A
- CFSB $7,484,000.00
- Revenue This Year
- RENB N/A
- CFSB N/A
- Revenue Next Year
- RENB N/A
- CFSB N/A
- P/E Ratio
- RENB N/A
- CFSB N/A
- Revenue Growth
- RENB N/A
- CFSB N/A
- 52 Week Low
- RENB $0.22
- CFSB $6.41
- 52 Week High
- RENB $2.10
- CFSB $13.98
- Technical
- Relative Strength Index (RSI)
- RENB 51.07
- CFSB 67.93
- Support Level
- RENB $0.22
- CFSB $13.86
- Resistance Level
- RENB $0.25
- CFSB $13.95
- Average True Range (ATR)
- RENB 0.02
- CFSB 0.01
- MACD
- RENB 0.00
- CFSB -0.01
- Stochastic Oscillator
- RENB 84.44
- CFSB 85.71
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
About CFSB CFSB Bancorp Inc.
CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.